|
FAM72D expression based on
|
KIRP : Kidney renal papillary cell carcinoma *
Please note that the TPM values for gene considered is extremely low (TPM < 1).
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.87072579649339E-13 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.10150000001796E-06 |
| Normal-vs-Stage2 |
3.054300E-02 |
| Normal-vs-Stage3 |
6.13999999999892E-05 |
| Normal-vs-Stage4 |
3.590300E-02 |
| Stage1-vs-Stage2 |
3.452400E-01 |
| Stage1-vs-Stage3 |
5.342700E-03 |
| Stage1-vs-Stage4 |
8.888300E-02 |
| Stage2-vs-Stage3 |
1.325420E-01 |
| Stage2-vs-Stage4 |
1.548820E-01 |
| Stage3-vs-Stage4 |
4.308200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.05171468492927E-12 |
| Normal-vs-AfricanAmerican |
5.022100E-04 |
| Normal-vs-Asian |
9.648200E-02 |
| Caucasian-vs-AfricanAmerican |
3.338200E-01 |
| Caucasian-vs-Asian |
4.295400E-01 |
| AfricanAmerican-vs-Asian |
1.939850E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.27684537890127E-12 |
| Normal-vs-Female |
1.407330E-04 |
| Male-vs-Female |
6.761600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.387300E-04 |
| Normal-vs-Extreme_Weight |
5.69810000294879E-08 |
| Normal-vs-Obese |
4.58589999974279E-07 |
| Normal-vs-Extreme_Obese |
8.545800E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.599600E-02 |
| Normal_Weight-vs-Obese |
5.120200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.117600E-02 |
| Extreme_Weight-vs-Obese |
4.858000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.713400E-01 |
| Obese-vs-Extreme_Obese |
1.397650E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.524600E-03 |
| Normal-vs-Age(41-60Yrs) |
3.82950005040072E-10 |
| Normal-vs-Age(61-80Yrs) |
1.72929999997518E-06 |
| Normal-vs-Age(81-100Yrs) |
5.243100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.540000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.481600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.241730E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.904400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.008100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.645800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.02429953408034E-10 |
| Normal-VS-Type2 PRCC |
1.023490E-04 |
| Normal-VS-KIRP CIMP |
1.760620E-04 |
| Normal-VS-Unclassified PRCC |
1.152790E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.228200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.567300E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
1.312760E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.21569999955717E-07 |
| Type2 PRCC-VS-Unclassified PRCC |
7.555000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.442600E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.823400E-04 |
| Normal-vs-N1 |
3.94940000000288E-05 |
| Normal-vs-N2 |
1.049380E-01 |
| N0-vs-N1 |
8.432300E-04 |
| N0-vs-N2 |
2.888000E-02 |
| N1-vs-N2 |
6.033400E-01 |
|
|
